198 related articles for article (PubMed ID: 37701171)
21. Central nervous system infection with Toxoplasma gondii.
Marra CM
Handb Clin Neurol; 2018; 152():117-122. PubMed ID: 29604970
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug Administration.
Sande MA; Whitley RJ; McCracken GH; Lentnek A; Scheld WM
Clin Infect Dis; 1992 Nov; 15 Suppl 1():S200-5. PubMed ID: 1477231
[TBL] [Abstract][Full Text] [Related]
23. Unusual Toxoplasma infection of the eye and central nervous system in an HIV-positive patient.
Ondriska F; Soják Ľ; Boldiš V; Piesecká Ľ; Mikula P; Kováč Ľ
Epidemiol Mikrobiol Imunol; 2022; 71(3):165-170. PubMed ID: 36257796
[TBL] [Abstract][Full Text] [Related]
24. Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resource-poor setting in Burkina Faso.
Bamba S; Zoungrana J; Nikièma Z; Sondo AK; Ndiaye JL; Bretagne S
Ann Parasitol; 2017; 63(3):173–181. PubMed ID: 29274210
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a PCR assay for diagnosis of toxoplasmosis in serum and peripheral blood mononuclear cell among HIV/AIDS patients.
Bokharaei-Salim F; Esteghamati A; Khanaliha K; Kalantari S; Sayyahfar S; Donyavi T; Garshasbi S; Asgari Q; Salemi B
J Parasit Dis; 2020 Mar; 44(1):159-165. PubMed ID: 32174720
[TBL] [Abstract][Full Text] [Related]
26. [Retrospective evaluation of the detection of Toxoplasma gondii by polymerase chain reaction in AIDS patients].
Robert F; Ouatas T; Blanche P; Tourte-Schaefer C; Sicard D; Dupouy-Camet J
Presse Med; 1996 Mar; 25(11):541-5. PubMed ID: 8731798
[TBL] [Abstract][Full Text] [Related]
27. Toxoplasmosis in HIV infection: An overview.
Basavaraju A
Trop Parasitol; 2016; 6(2):129-135. PubMed ID: 27722101
[No Abstract] [Full Text] [Related]
28. Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis.
Letillois MF; Laigle V; Santoro F; Micoud M; Chumpitazi BF
Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):899-903. PubMed ID: 8605904
[TBL] [Abstract][Full Text] [Related]
29. Intra-cranial Toxoplasmosis in an Immunocompetent Female.
Hoti YU; Aziz A; Ishaque K; Abbas S; Ud Din TS
J Coll Physicians Surg Pak; 2016 Jun; 26(6 Suppl):S39-41. PubMed ID: 27376217
[TBL] [Abstract][Full Text] [Related]
30. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis.
Khalifa K el-S ; Roth A; Roth B; Arasteh KN; Janitschke K
J Clin Microbiol; 1994 Nov; 32(11):2813-9. PubMed ID: 7852576
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome.
Oksenhendler E; Cadranel J; Sarfati C; Katlama C; Datry A; Marche C; Wolf M; Roux P; Derouin F; Clauvel JP
Am J Med; 1990 May; 88(5N):18N-21N. PubMed ID: 2368769
[TBL] [Abstract][Full Text] [Related]
32. Immunodiagnostics of cerebral toxoplasmosis depending on permeability of blood-brain barrier.
Bondarenko AV; Katsapov DV; Gavrylov AV; Didova TV; Nahornyi IA
Wiad Lek; 2020; 73(2):285-288. PubMed ID: 32248160
[TBL] [Abstract][Full Text] [Related]
33. Spinal cord toxoplasmosis in human immunodeficiency virus infection/acquired immunodeficiency syndrome.
García-García C; Castillo-Álvarez F; Azcona-Gutiérrez JM; Herraiz MJ; Ibarra V; Oteo JA
Infect Dis (Lond); 2015 May; 47(5):277-82. PubMed ID: 25835092
[TBL] [Abstract][Full Text] [Related]
34. In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patients.
Vendrell JP; Reynes J; Huguet MF; Ngou J; Michard C; Atoui N; Pratlong F; Segondy M; Serre A
Lancet; 1993 Jul; 342(8862):22-3. PubMed ID: 8100291
[TBL] [Abstract][Full Text] [Related]
35. Intracranial inflammatory granuloma caused by toxoplasmosis.
Li ZH; Guo FY; Wang ZQ; Cui J
Pathog Glob Health; 2014 Jul; 108(5):255-9. PubMed ID: 25175876
[TBL] [Abstract][Full Text] [Related]
36. Serological Responses to Toxoplasma gondii and Matrix Antigen 1 Predict the Risk of Subsequent Toxoplasmic Encephalitis in People Living With Human Immunodeficiency Virus (HIV).
Xiao J; Bhondoekhan F; Seaberg EC; Yang O; Stosor V; Margolick JB; Yolken RH; Viscidi RP
Clin Infect Dis; 2021 Oct; 73(7):e2270-e2277. PubMed ID: 33388768
[TBL] [Abstract][Full Text] [Related]
37. Single thalamic localization of brain toxoplasmosis mimicking brain tumors: Radiological and clinical findings.
DiPellegrini G; Boccaletti R; Mingozzi A; Fara A; Policicchio D
Surg Neurol Int; 2023; 14():82. PubMed ID: 37025531
[TBL] [Abstract][Full Text] [Related]
38. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS.
Eggers C; Gross U; Klinker H; Schalke B; Stellbrink HJ; Kunze K
J Neurol; 1995 Oct; 242(10):644-9. PubMed ID: 8568525
[TBL] [Abstract][Full Text] [Related]
39. Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients.
Kodym P; Malý M; Beran O; Jilich D; Rozsypal H; Machala L; Holub M
Epidemiol Infect; 2015 Feb; 143(3):600-7. PubMed ID: 24850323
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar toxoplasmosis in HIV/AIDS: a case report.
Emeka EU; Ogunrin AO; Olubunmi A
West Afr J Med; 2010; 29(2):123-6. PubMed ID: 20544640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
